Cara Therapeutics reported $1M in Trade Debtors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 51.82M 5.57M
Acelrx Pharmaceuticals ACRX:US $ 104K 554K
Aerie Pharmaceuticals AERI:US $ 59.15M 13M
Antares Pharma ATRS:US $ 59.95M 6.05M
Biodelivery Sciences International BDSI:US $ 52.87M 4.58M
Cara Therapeutics CARA:US $ 1M 2.75M
Chugai Pharma 4519:JP Y 293356M 50132M
Depomed DEPO:US $ 45.47M 6.23M
Endo International Ordinary Shares ENDP:US $ 467.92M 14.24M
Halozyme Therapeutics HALO:US $ 153.2M 64.81M
Horizon Pharma HZNP:US $ 735.43M 292.26M
JAZZ PHA JAZZ:US $ 506.66M 92.68M
Neurocrine Biosciences NBIX:US $ 158.5M 10.7M
Pacira Pharmaceuticals PCRX:US $ 68.36M 15.77M
Redhill Biopharma RDHL:US $ 30.1M 6.79M
Revance Therapeutics RVNC:US $ 641K 4.54M
Supernus Pharmaceuticals SUPN:US $ 137.28M 10.21M
Teva Pharmaceutical Industries TEVA:US $ 4488M 84M
Vanda Pharmaceuticals VNDA:US $ 37.09M 5.62M